Related Experiment Video
Updated: May 21, 2026
04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Mood stabilizer psychopharmacology.
Todd D Gould1, Guang Chen, Husseini K Manji
1Laboratory of Molecular Pathophysiology, Building 49, Room B1EE16, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA.
Clinical Neuroscience Research
|June 19, 2012
Summary
Mood stabilizers like lithium are effective for bipolar disorder, targeting intracellular pathways for mood regulation and neuroprotection. Further research into these mechanisms may improve treatments for bipolar and neurodegenerative disorders.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Mood stabilizers are primary treatments for bipolar disorder, including lithium, valproic acid, and carbamazepine.
- These medications manage acute manic episodes, prevent future episodes, and serve as adjunctive antidepressants.
Purpose of the Study:
- To review the common and unique intracellular effects of mood stabilizers.
- To explore the therapeutic targets and mechanisms of action of these drugs.
- To discuss the implications for understanding bipolar disorder pathophysiology and developing new treatments.
Main Methods:
- Review of existing scientific literature on mood stabilizer mechanisms.
- Analysis of intracellular targets including enzymes, ion channels, and signaling pathways.
Main Results:
- Mood stabilizers modulate intracellular enzymes, ion channels, arachidonic acid metabolism, and G protein-coupled receptors.
- Key targets involve intracellular pathways crucial for synaptic plasticity and neuroprotection.
- Evidence suggests therapeutically relevant actions occur intracellularly.
Conclusions:
- Understanding mood stabilizer intracellular targets enhances comprehension of bipolar disorder.
- This knowledge facilitates the development of improved therapeutics for bipolar disorder.
- Mood stabilizers' neuroprotective pathways suggest potential applications in neurodegenerative diseases.
Related Concept Videos
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...